Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Rafael Holdings Inc RFL

Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. Its segments include Healthcare, Infusion Technology and Real Estate. The Healthcare segment holds interest in LipoMedix Pharmaceuticals Ltd. (LipoMedix), Barer Institute Inc. (Barer), Cornerstone Pharmaceuticals, Inc. (Cornerstone) and Rafael Medical Devices, LLC. The Real Estate... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:RFL)

Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results

GlobeNewswire June 14, 2024

Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC(TM) Trial of Niemann-Pick Type C1

Business Wire May 30, 2024

Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results

GlobeNewswire March 13, 2024

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

GlobeNewswire December 14, 2023

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results

Business Wire November 15, 2023

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

GlobeNewswire October 30, 2023

Cyclo Therapeutics Reports Second Quarter 2023 Financial Results

Business Wire August 15, 2023

Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.

Business Wire August 2, 2023

Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update

GlobeNewswire June 13, 2023
View More News ››

Opinion & Analysis (NYSE:RFL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:RFL)

5 REASONS WHY RAFAEL HOLDINGS IS A RISKY INVESTMENT!

$RFL   Rafael Holdings Inc, whose subsidiaries include Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd, has...
AviseAnalytics - November 29, 2021
View more Bullboard ››

Nanalysis Scientific Corp.

Nanalysis Scientific Corp.

Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for ...
View More »